Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 464 participants.
Also called NCT02313584
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 464 participants
- Sponsor
- Registry
-
NCT02313584
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02313584. Randomized; no masking; primary purpose prevention. Start 2014-12 (registry gives no type); primary completion 2016-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk
- Condition
- Atrial Fibrillation
- Condition
- Thromboembolism
- Intervention (Drug)
- dabigatran
- Intervention (Drug)
- placebo
- Lead sponsor
- Korea University
Record details
- Record id
cardio:ct-nct02313584- Content hash
c6f8538bab5998b0adc80d3fe3ed5a1cc17870654b179dd70651b3d857b1ef57